ArticleJournal of gastrointestinal oncology2025
Predicting the prognosis of hepatocellular carcinoma after curative resection using a nomogram based on the ratio of prealbumin to platelet distribution width.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary liver cancer (PLC) is one of the most common malignant tumors worldwide, with its incidence continuing to rise in recent years. As the main pathological subtype of PLC, hepatocellular carcinoma (HCC) has become a major disease burden threatening global public health. For HCC patients receiving treatment, accurate prognostic stratification is of crucial significance for improving patients' long-term survival. In view of this, this study was designed to explore the predictive value of the ratio of the preoperative prealbumin to the platelet distribution width (PDW), namely, the PPDWR, for the prognosis of HCC following radical resection. Additionally, a nomogram was constructed for survival prediction. Methods: A retrospective analysis was carried out on the data of 205 patients who underwent radical resection for HCC at The Affiliated Hospital of Southwest Medical University between January 2016 and August 2021. These patients were randomly assigned to a training set or a validation set. The optimal cutoff value of the PPDWR was determined by the receiver operating characteristic (ROC) curve of overall survival (OS) in the training set of patients, after which patients were grouped accordingly. The associations between PPDWR and clinical characteristics, as well as its impact on survival, were analyzed. Prognosis-related variables were screened via least absolute shrinkage and selection operator (LASSO)-Cox regression and univariate and multivariate Cox regression. Nomograms for OS and recurrence-free survival (RFS) were subsequently constructed and validated. Finally, the time-dependent ROC curve, concordance index and decision curve analysis were used for survival prediction evaluation. P<0.05 indicated a statistically significant difference. Results: The optimal cutoff value of the PPDWR was 14.514 which was correlated with multiple clinical indices. The sensitivity and specificity of this cutoff value were 88.5% and 45.1%, respectively. The OS and RFS of patients in the high-PPDWR subgroup were significantly superior to those in the low-PPDWR subgroup. A low PPDWR level, a high alpha-fetoprotein (AFP) level, were independent risk factors for OS. For RFS, the independent risk factors included a low PPDWR, China Liver Cancer Staging (CNLC) stage III. The constructed nomograms demonstrated good predictive accuracy in both the training set and the validation set. Conclusions: A low preoperative PPDWR is an independent risk factor for poor postoperative prognosis in HCC patients. The nomogram constructed on the basis of the PPDWR can effectively predict the postoperative OS and RFS of patients, thus offering a reference for clinical treatment decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.